Navigation Links
Varian Medical Systems to Display Medical X-Ray Tubes and PaxScan® Digital X-Ray Image Detectors at MEDICA 2010 International Trade Fair

SALT LAKE CITY, Nov. 17, 2010 /PRNewswire/ -- Booth - A78/Hall 10 -- Varian Medical Systems will exhibit its line of PaxScan® digital image detectors and X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the MEDICA 2010 International Trade Fair in Dusseldorf, Germany from November 17-20.

The Varian booth will showcase several filmless imaging detectors and X-ray tube products, including:

  • The PaxScan® 3030+, a 30cm x 30cm real-time digital imaging panel that operates at speeds up to 30 fps, enables physicians to monitor interventional procedures, including placement of catheters within blood vessels, in real-time. The multi-modality panel is also designed for use in cardiovascular imaging systems and surgical C-arms. The 194 micron pixel pitch results in images with high spatial and contrast resolution needed by critical applications such as cardiology and angiography.
  • The PaxScan 4336R, a 43cm x 36cm DR panel that is the first ISO 4090 industry standard size panel designed to replace standard film cassettes used in existing radiographic and multi-bucky applications. The panel is also available with a portable hand-held enclosure for use in mobile imaging systems.
  • Varian's line of X-ray tubes for medical and dental applications.

  • "Through our bonded service center in the Dusseldorf area, we carry an inventory of X-ray tubes and flat panel detectors for immediate delivery throughout the European region," said Stefano Daniotti, manager European sales & service group. "We are able to offer our customers the largest selection of X-ray tubes and digital image detectors in the world," added Daniotti. The facility reloads, rebuilds and distributes medical X-ray tubes for immediate delivery. It also provides evaluation, repair, and replacement tubes. Varian's X-ray Products group is headquartered in Salt Lake City, Utah.

    About Varian Medical SystemsVarian X-Ray Products is a premier supplier of X-ray tubes and digital detectors for X-ray imaging in medical, dental, veterinary, scientific, and industrial applications. X-Ray Products is a business unit of Varian Medical Systems, Inc., of Palo Alto, California. Varian is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. The company also supplies X-ray imaging products for cargo screening and industrial non-destructive inspection. Varian Medical Systems employs approximately 5,300 people who are located at manufacturing sites in North America, China and Europe and in its 70 sales and support offices around the world. For more information, visit INFORMATION CONTACT:Elaine Rebele, Varian Medical Systems801-978-5715

    SOURCE Varian Medical Systems, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
    2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
    3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
    4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
    5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
    6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
    7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
    8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
    9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
    10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
    11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
    Post Your Comments:
    (Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
    (Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
    (Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: ... a number of ,world firsts,: , TwinLink™ ...
    Breaking Medicine Technology:
    (Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
    (Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
    (Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
    (Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
    (Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
    Breaking Medicine News(10 mins):